Lipum AB (publ) (STO:LIPUM)
Sweden · Delayed Price · Currency is SEK 14.55
+0.25 (1.75%)
Feb 26, 2026, 4:39 PM CET
Lipum AB Revenue
In the year 2025, Lipum AB had annual revenue of 1.93M SEK. Lipum AB had revenue of 712.00K in the quarter ending December 31, 2025.
Revenue
1.93M
Revenue Growth
n/a
P/S Ratio
157.25
Revenue / Employee
385.80K
Employees
5
Market Cap
303.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.93M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sprint Bioscience AB | 167.17M |
| Bio-Works Technologies AB | 63.11M |
| Intervacc AB | 20.09M |
| NextCell Pharma AB | 11.06M |
| Elicera Therapeutics AB | 10.86M |
| Corline Biomedical AB | 8.59M |
| Xintela AB | 2.96M |
| Mendus AB | -1.44M |